Volume 139, Issue 4, Pages 1165-1171.e4 (October 2010) Histamine2-Receptor Antagonists Are an Alternative to Proton Pump Inhibitor in Patients Receiving Clopidogrel  Chun–Ying Wu, Francis Ka–Leung Chan, Ming–Shiang Wu, Ken N. Kuo, Chang–Bi Wang, Chen–Rong Tsao, Jaw–Town Lin  Gastroenterology  Volume 139, Issue 4, Pages 1165-1171.e4 (October 2010) DOI: 10.1053/j.gastro.2010.06.067 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Cumulative incidences of all-cause mortality or rehospitalization for acute coronary syndrome for clopidogrel plus H2RA cohort, clopidogrel plus PPI cohort, clopidogrel alone cohort, H2RA alone cohort, and PPI alone cohort. Gastroenterology 2010 139, 1165-1171.e4DOI: (10.1053/j.gastro.2010.06.067) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 1 (A) Cumulative incidence rates of rehospitalization for acute coronary syndrome (ACS). (B) Cumulative incidence rates of revascularization procedures or coronary artery bypass graft surgery. (C) Cumulative incidence rates of all-cause mortality within 3 months of rehospitalization. Gastroenterology 2010 139, 1165-1171.e4DOI: (10.1053/j.gastro.2010.06.067) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 2 Cumulative incidences of all-cause mortality or rehospitalization for ACS for current users. Gastroenterology 2010 139, 1165-1171.e4DOI: (10.1053/j.gastro.2010.06.067) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 3 (A) Cumulative incidences of all-cause mortality or rehospitalization for ACS not excluding patients who had ACS events in the first month after the index hospitalization. (B) Cumulative incidence rates of rehospitalization for ACS not excluding patients who had ACS events in the first month after the index hospitalization. (C) Cumulative incidence rates of revascularization procedures or coronary artery bypass graft surgery for ACS not excluding patients who had ACS events in the first month after the index hospitalization. (D) Cumulative incidence rates of all-cause mortality not excluding patients who had ACS events in the first month after the index hospitalization. Gastroenterology 2010 139, 1165-1171.e4DOI: (10.1053/j.gastro.2010.06.067) Copyright © 2010 AGA Institute Terms and Conditions